• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床路径有效性证据基础的质量:评估试验设计有改进的空间。

The quality of the evidence base for clinical pathway effectiveness: room for improvement in the design of evaluation trials.

机构信息

Office of the Dean, School for Public Health and Primary Care, Medicine & Life Sciences, Maastricht University, Maastricht, The Netherlands.

出版信息

BMC Med Res Methodol. 2012 Jun 18;12:80. doi: 10.1186/1471-2288-12-80.

DOI:10.1186/1471-2288-12-80
PMID:22709274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3424110/
Abstract

BACKGROUND

The purpose of this article is to report on the quality of the existing evidence base regarding the effectiveness of clinical pathway (CPW) research in the hospital setting. The analysis is based on a recently published Cochrane review of the effectiveness of CPWs.

METHODS

An integral component of the review process was a rigorous appraisal of the methodological quality of published CPW evaluations. This allowed the identification of strengths and limitations of the evidence base for CPW effectiveness. We followed the validated Cochrane Effective Practice and Organisation of Care Group (EPOC) criteria for randomized and non-randomized clinical pathway evaluations. In addition, we tested the hypotheses that simple pre-post studies tend to overestimate CPW effects reported.

RESULTS

Out of the 260 primary studies meeting CPW content criteria, only 27 studies met the EPOC study design criteria, with the majority of CPW studies (more than 70 %) excluded from the review on the basis that they were simple pre-post evaluations, mostly comparing two or more annual patient cohorts. Methodologically poor study designs are often used to evaluate CPWs and this compromises the quality of the existing evidence base.

CONCLUSIONS

Cochrane EPOC methodological criteria, including the selection of rigorous study designs along with detailed descriptions of CPW development and implementation processes, are recommended for quantitative evaluations to improve the evidence base for the use of CPWs in hospitals.

摘要

背景

本文旨在报告现有关于临床路径(CPW)在医院环境中有效性的证据基础的质量。该分析基于最近发表的 Cochrane 综述,对 CPWs 的有效性进行评估。

方法

综述过程的一个组成部分是对已发表的 CPW 评估的方法学质量进行严格评估。这使得能够确定 CPW 有效性证据基础的优缺点。我们遵循经过验证的 Cochrane 有效实践和组织护理小组(EPOC)标准,对随机和非随机临床路径评估进行评估。此外,我们还检验了以下假设,即简单的前后研究往往会高估 CPW 报告的效果。

结果

在符合 CPW 内容标准的 260 项主要研究中,只有 27 项研究符合 EPOC 研究设计标准,而大多数 CPW 研究(超过 70%)由于采用简单的前后评估,大多比较两个或多个年度患者队列,而被排除在综述之外。方法学上较差的研究设计通常用于评估 CPWs,这会影响现有证据基础的质量。

结论

建议采用 Cochrane EPOC 方法学标准,包括选择严格的研究设计以及详细描述 CPW 的开发和实施过程,对 CPWs 在医院中的使用进行定量评估,以提高证据基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/065489d55511/1471-2288-12-80-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/93f7c4d180af/1471-2288-12-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/24b179ac604b/1471-2288-12-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/065489d55511/1471-2288-12-80-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/93f7c4d180af/1471-2288-12-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/24b179ac604b/1471-2288-12-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ed/3424110/065489d55511/1471-2288-12-80-3.jpg

相似文献

1
The quality of the evidence base for clinical pathway effectiveness: room for improvement in the design of evaluation trials.临床路径有效性证据基础的质量:评估试验设计有改进的空间。
BMC Med Res Methodol. 2012 Jun 18;12:80. doi: 10.1186/1471-2288-12-80.
2
What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review.什么是临床路径?为Cochrane系统评价确定临床路径研究而对操作定义进行的细化。
BMC Med. 2016 Feb 23;14:35. doi: 10.1186/s12916-016-0580-z.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.
5
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
6
How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?“护理路径技术”对卒中护理服务整合的影响是如何衡量的,以及有哪些证据支持其在这方面的有效性?
Int J Evid Based Healthc. 2008 Mar;6(1):78-110. doi: 10.1111/j.1744-1609.2007.00098.x.
7
Effects of Clinical Pathways for COPD on Patient, Professional, and Systems Outcomes: A Systematic Review.慢性阻塞性肺疾病临床路径对患者、专业人员和系统结局的影响:系统评价。
Chest. 2019 Nov;156(5):864-877. doi: 10.1016/j.chest.2019.04.131. Epub 2019 May 28.
8
The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.临床前和临床研究、系统评价与荟萃分析以及临床实践指南的方法学质量评估工具:一项系统评价。
J Evid Based Med. 2015 Feb;8(1):2-10. doi: 10.1111/jebm.12141.
9
Are the outcomes of clinical pathways evidence-based? A critical appraisal of clinical pathway evaluation research.临床路径的结果是基于证据的吗?对临床路径评估研究的批判性评价。
J Eval Clin Pract. 2007 Dec;13(6):920-9. doi: 10.1111/j.1365-2753.2006.00774.x.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
Clinical pathways for secondary care and the effects on professional practice, patient outcomes, length of stay and hospital costs.二级医疗的临床路径及其对专业实践、患者结局、住院时间和医院成本的影响。
Cochrane Database Syst Rev. 2025 May 14;5(5):CD006632. doi: 10.1002/14651858.CD006632.pub3.
2
A New Benchmark for Modern Management of Valvular Heart Disease: The Whole-Life Cycle Management System.心脏瓣膜病现代管理的新基准:全生命周期管理系统
JACC Asia. 2025 May;5(5):609-632. doi: 10.1016/j.jacasi.2025.01.017. Epub 2025 Apr 8.
3
Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative Care.

本文引用的文献

1
What is a clinical pathway? Development of a definition to inform the debate.什么是临床路径?一个定义的发展,以提供信息的辩论。
BMC Med. 2010 May 27;8:31. doi: 10.1186/1741-7015-8-31.
2
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs.临床路径:对专业实践、患者结局、住院时间和医院成本的影响。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD006632. doi: 10.1002/14651858.CD006632.pub2.
3
Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial.
姑息治疗中疲劳评估与治疗护理路径的制定
Indian J Palliat Care. 2023 Jul-Sep;29(3):256-265. doi: 10.25259/IJPC_194_2022. Epub 2023 Jan 11.
4
Effectiveness, quality and implementation of pain, sedation, delirium, and iatrogenic withdrawal syndrome algorithms in pediatric intensive care: a systematic review and meta-analysis.儿科重症监护中疼痛、镇静、谵妄和医源性戒断综合征算法的有效性、质量及实施情况:一项系统评价和荟萃分析
Front Pediatr. 2023 Jun 16;11:1204622. doi: 10.3389/fped.2023.1204622. eCollection 2023.
5
Associations between clinical pathway concordance, cost, and survival outcomes for stage II colon cancer: a population-based study.临床路径一致性、成本与 II 期结肠癌生存结局的相关性:一项基于人群的研究。
Int J Qual Health Care. 2023 Apr 5;35(2). doi: 10.1093/intqhc/mzad012.
6
Changing the routine: a move to patient initiated follow up to improve surgical outpatient clinic.改变常规:采用患者主动随访以改进外科门诊。
ANZ J Surg. 2022 Jun;92(6):1394-1400. doi: 10.1111/ans.17676. Epub 2022 Apr 16.
7
The Design and Evaluation of Clinical Pathway for Disease Management to Maximize Public Health Benefit.以最大化公共卫生效益为目标的疾病管理临床路径的设计与评估
Risk Manag Healthc Policy. 2021 Dec 18;14:5047-5057. doi: 10.2147/RMHP.S340718. eCollection 2021.
8
Development of a Model Care Pathway for Myasthenia Gravis.重症肌无力模型护理路径的制定。
Int J Environ Res Public Health. 2021 Nov 4;18(21):11591. doi: 10.3390/ijerph182111591.
9
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway.在挪威中部农村地区实施整合肿瘤学、姑息治疗和社区护理的标准化护理路径。
Oncol Ther. 2021 Dec;9(2):671-693. doi: 10.1007/s40487-021-00176-y. Epub 2021 Nov 3.
10
Online clinical pathway for chronic kidney disease management in primary care: a retrospective cohort study.在线慢性肾脏病管理临床路径在基层医疗中的应用:一项回顾性队列研究。
BMC Nephrol. 2021 Oct 6;22(1):332. doi: 10.1186/s12882-021-02533-5.
双相情感障碍的协作护理:第一部分。随机有效性试验中的干预与实施
Psychiatr Serv. 2006 Jul;57(7):927-36. doi: 10.1176/ps.2006.57.7.927.
4
Effects of counseling and implementation of clinical pathway on diabetic patients hospitalized with hypoglycemia.咨询及实施临床路径对低血糖住院糖尿病患者的影响。
J Med Assoc Thai. 2006 May;89(5):619-25.
5
Evidence-based implementation of evidence-based guidelines.基于证据的指南的循证实施。
Int J Health Care Qual Assur Inc Leadersh Health Serv. 2006;19(1):32-41. doi: 10.1108/09526860610642582.
6
Impact on readmission rates and mortality of a chronic obstructive pulmonary disease inpatient management guideline.慢性阻塞性肺疾病住院患者管理指南对再入院率和死亡率的影响
Chron Respir Dis. 2004;1(1):17-28. doi: 10.1191/1479972304cd007oa.
7
An evaluation of the impact of the ventilator care bundle.对呼吸机护理集束的影响评估。
Nurs Crit Care. 2005 Sep-Oct;10(5):242-6. doi: 10.1111/j.1362-1017.2005.00134.x.
8
Improving end-of-life care: development and pilot-test of a clinical pathway.改善临终关怀:临床路径的制定与试点测试
J Pain Symptom Manage. 2005 Jun;29(6):529-43. doi: 10.1016/j.jpainsymman.2004.05.011.
9
The development and establishment of a care map in children with asthma in Taiwan.台湾地区儿童哮喘照护地图的制定与建立。
J Asthma. 2004;41(8):855-61. doi: 10.1081/jas-200038471.
10
[Electronic clinical pathway for community acquired pneumonia (e-CP CAP)].[社区获得性肺炎电子临床路径(e-CP CAP)]
Nihon Kokyuki Gakkai Zasshi. 2004 Jul;42(7):620-4.